RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Tanise L. Jackson to In Situ Nick-End Labeling

Back to Details
This is a "connection" page, showing publications Tanise L. Jackson has written about In Situ Nick-End Labeling.
Tanise L. Jackson
Connection Strength
0.034
In Situ Nick-End Labeling
  1. Fulzele SV, Chatterjee A, Shaik MS, Jackson T, Ichite N, Singh M. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors. Anticancer Drugs. 2007 Jan; 18(1):65-78.
    View in: PubMed
    Score: 0.018
  2. Shaik MS, Chatterjee A, Jackson T, Singh M. Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors. Int J Cancer. 2006 Jan 15; 118(2):396-404.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support